Followers

Sunday, October 18, 2020

Serum Institute, Bharat Biotech To Start Intranasal Vaccine Trials: Centre

Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health...

from NDTV News - Topstories https://ift.tt/3lXILh9

No comments:

Post a Comment

Loan-related complaints up 43% in FY24, says RBI report

Consumer complaints related to loans and advances rose 43%, representing 29% of the total grievances against RBI-regulated entities in FY24,...